Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ionis Pharmaceuticals Long Term Debt 2011-2025 | IONS

Ionis Pharmaceuticals long term debt from 2011 to 2025. Long term debt can be defined as the sum of all long term debt fields.
  • Ionis Pharmaceuticals long term debt for the quarter ending September 30, 2025 was $0.596B, a 51.7% decline year-over-year.
  • Ionis Pharmaceuticals long term debt for 2024 was $1.245B, a 1.3% increase from 2023.
  • Ionis Pharmaceuticals long term debt for 2023 was $1.23B, a 3.96% increase from 2022.
  • Ionis Pharmaceuticals long term debt for 2022 was $1.183B, a 3.69% decline from 2021.
Ionis Pharmaceuticals Annual Long Term Debt
(Millions of US $)
2024 $1,245
2023 $1,230
2022 $1,183
2021 $1,228
2020 $624
2019 $786
2018 $633
2017 $606
2016 $516
2015 $524
2014 $383
2013 $157
2012 $151
2011 $146
2010 $139
Ionis Pharmaceuticals Quarterly Long Term Debt
(Millions of US $)
2025-09-30 $596
2025-06-30 $625
2025-03-31 $1,251
2024-12-31 $1,245
2024-09-30 $1,234
2024-06-30 $1,232
2024-03-31 $1,231
2023-12-31 $1,230
2023-09-30 $1,279
2023-06-30 $1,315
2023-03-31 $1,177
2022-12-31 $1,183
2022-09-30 $1,250
2022-06-30 $1,248
2022-03-31 $1,248
2021-12-31 $1,228
2021-09-30 $1,242
2021-06-30 $1,241
2021-03-31 $871
2020-12-31 $624
2020-09-30 $815
2020-06-30 $804
2020-03-31 $795
2019-12-31 $786
2019-09-30 $656
2019-06-30 $663
2019-03-31 $654
2018-12-31 $633
2018-09-30 $624
2018-06-30 $625
2018-03-31 $614
2017-12-31 $606
2017-09-30 $598
2017-06-30 $532
2017-03-31 $523
2016-12-31 $516
2016-09-30 $423
2016-06-30 $404
2016-03-31 $398
2015-12-31 $524
2015-09-30 $399
2015-06-30 $394
2015-03-31 $388
2014-12-31 $383
2014-09-30 $159
2014-06-30 $158
2014-03-31 $158
2013-12-31 $157
2013-09-30 $155
2013-06-30 $154
2013-03-31 $152
2012-12-31 $151
2012-09-30 $151
2012-06-30 $156
2012-03-31 $147
2011-12-31 $146
2011-09-30 $144
2011-06-30 $143
2011-03-31 $140
2010-12-31 $139
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $11.264B $0.705B
Ionis Pharmaceuticals discovers/develops RNA-targeted therapeutics using its proprietary antisense oligonucleotide technology. Its antisense medicines have been developed/are being developed to treat neurological, cardiovascular and specialty rare diseases.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $78.129B 29.67
Zoetis (ZTS) United States $52.791B 18.89
Takeda Pharmaceutical (TAK) Japan $43.625B 8.90
Daiichi Sankyo, - (DSNKY) Japan $40.634B 20.24
BeOne Medicines - (ONC) Switzerland $36.101B 191.40
Sandoz Group AG (SDZNY) Switzerland $29.630B 0.00
United Therapeutics (UTHR) United States $19.545B 17.20
Merck (MKKGY) Germany $16.472B 10.71
Neurocrine Biosciences (NBIX) United States $14.958B 35.89
Shionogi (SGIOY) Japan $14.547B 13.36
Summit Therapeutics (SMMT) United States $14.112B 0.00
IPSEN (IPSEY) France $12.438B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.262B 0.00
Orion OYJ (ORINY) Finland $8.719B 24.91
Eisai (ESAIY) $8.283B 0.00
Corcept Therapeutics (CORT) United States $7.941B 85.78
Stevanato Group S.p.A (STVN) Italy $7.344B 41.10
Grifols, S.A (GRFS) Spain $5.913B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.730B 17.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.546B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.389B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.933B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.606B 17.13
Centessa Pharmaceuticals (CNTA) United Kingdom $2.990B 0.00
Hypermarcas (HYPMY) Brazil $2.983B 22.43
Procaps Group, S.A (PROCF) Luxembourg $2.926B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.650B 8.45
Dyne Therapeutics (DYN) United States $2.644B 0.00
Soleno Therapeutics (SLNO) United States $2.487B 0.00
Ocular Therapeutix (OCUL) United States $2.307B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.963B 23.27
Guardian Pharmacy Services (GRDN) United States $1.884B 36.28
Avadel Pharmaceuticals (AVDL) Ireland $1.816B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.516B 90.00
Collegium Pharmaceutical (COLL) United States $1.376B 6.81
Ardelyx (ARDX) United States $1.373B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.338B 0.00
Xeris Biopharma Holdings (XERS) United States $1.281B 0.00
Harrow (HROW) United States $1.263B 77.59
Nektar Therapeutics (NKTR) United States $1.179B 0.00
Oruka Therapeutics (ORKA) United States $1.161B 0.00
Enliven Therapeutics (ELVN) United States $1.108B 0.00
Relay Therapeutics (RLAY) United States $1.069B 0.00
Evotec AG (EVO) Germany $1.062B 0.00
Xencor (XNCR) United States $0.981B 0.00
Cronos Group (CRON) Canada $0.980B 0.00
ARS Pharmaceuticals (SPRY) United States $0.878B 0.00
Organogenesis (ORGO) United States $0.830B 0.00
ProKidney (PROK) United States $0.795B 0.00
Theravance Biopharma (TBPH) United States $0.759B 32.08
Savara (SVRA) United States $0.691B 0.00
Esperion Therapeutics (ESPR) United States $0.689B 0.00
Aquestive Therapeutics (AQST) United States $0.681B 0.00
Elite Pharmaceuticals (ELTP) United States $0.680B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.627B 5.60
Bioventus (BVS) United States $0.619B 12.69
KalVista Pharmaceuticals (KALV) United States $0.550B 0.00
Zevra Therapeutics (ZVRA) United States $0.512B 0.00
4D Molecular Therapeutics (FDMT) United States $0.475B 0.00
Siga Technologies (SIGA) United States $0.466B 6.38
Lexeo Therapeutics (LXEO) United States $0.460B 0.00
Altimmune (ALT) United States $0.445B 0.00
Akebia Therapeutics (AKBA) United States $0.443B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.411B 9.73
USANA Health Sciences (USNA) United States $0.351B 9.79
Nature's Sunshine Products (NATR) United States $0.346B 20.60
Lyell Immunopharma (LYEL) United States $0.340B 0.00
Galectin Therapeutics (GALT) United States $0.335B 0.00
Aldeyra Therapeutics (ALDX) United States $0.309B 0.00
Korro Bio (KRRO) United States $0.306B 0.00
Pyxis Oncology (PYXS) United States $0.297B 0.00
Larimar Therapeutics (LRMR) United States $0.294B 0.00
Achieve Life Sciences (ACHV) Canada $0.237B 0.00
Journey Medical (DERM) United States $0.235B 0.00
Aclaris Therapeutics (ACRS) United States $0.231B 0.00
OmniAb (OABI) United States $0.214B 0.00
AleAnna (ANNA) United States $0.214B 0.00
Heron Therapeutics (HRTX) United States $0.204B 0.00
Avalo Therapeutics (AVTX) United States $0.200B 0.00
MediWound (MDWD) Israel $0.199B 0.00
Profound Medical (PROF) Canada $0.181B 0.00
Protara Therapeutics (TARA) United States $0.175B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.165B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.148B 0.00
Cassava Sciences (SAVA) United States $0.146B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.128B 0.00
Incannex Healthcare (IXHL) Australia $0.126B 0.00
Avita Medical (RCEL) United States $0.121B 0.00
Inhibikase Therapeutics (IKT) United States $0.118B 0.00
Context Therapeutics (CNTX) United States $0.110B 0.00
Cardiol Therapeutics (CRDL) Canada $0.104B 0.00
Surrozen (SRZN) United States $0.101B 0.00
Relmada Therapeutics (RLMD) United States $0.100B 0.00
Vivani Medical (VANI) United States $0.096B 0.00
Champions Oncology (CSBR) United States $0.093B 33.90
Karyopharm Therapeutics (KPTI) United States $0.093B 0.00
VAXART, INC (VXRT) United States $0.091B 0.00
Gain Therapeutics (GANX) United States $0.090B 0.00
Unicycive Therapeutics (UNCY) United States $0.083B 0.00
Metagenomi (MGX) United States $0.081B 0.00
Lite Strategy (LITS) United States $0.081B 0.00
Dominari Holdings (DOMH) United States $0.080B 0.00
Assertio Holdings (ASRT) United States $0.077B 0.00
Plus Therapeutics (PSTV) United States $0.077B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Prelude Therapeutics (PRLD) United States $0.071B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
Rafael Holdings (RFL) United States $0.067B 0.00
Acrivon Therapeutics (ACRV) United States $0.064B 0.00
BioNxt Solutions (BNXTF) Canada $0.062B 0.00
PolyPid (PYPD) Israel $0.059B 0.00
Talphera (TLPH) United States $0.059B 0.00
Fractyl Health (GUTS) United States $0.056B 0.00
Wellgistics Health (WGRX) United States $0.053B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
ElectroCore (ECOR) United States $0.050B 0.00
Jupiter Neurosciences (JUNS) United States $0.048B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
FibroGen (FGEN) United States $0.044B 0.00
Telomir Pharmaceuticals (TELO) United States $0.044B 0.00
Tempest Therapeutics (TPST) United States $0.043B 0.00
Klotho Neurosciences (KLTO) United States $0.039B 0.00
Inotiv (NOTV) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Liminatus Pharma (LIMN) United States $0.032B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.030B 24.75
Iterum Therapeutics (ITRM) Ireland $0.029B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Scienture Holdings (SCNX) United States $0.024B 0.00
Mangoceuticals (MGRX) United States $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
Vyome Holdings (HIND) United States $0.020B 0.00
Heatwurx (PCSA) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
Traws Pharma (TRAW) United States $0.014B 0.02
Ainos (AIMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
BioVie (BIVI) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
CDT Equity (CDT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 15.76
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00